Current through the 2024 Legislative Session
Section 34-51-2 - Eligible patient definedFor the purposes of this chapter, the term, eligible patient, means a patient who meets all the following qualifications:
(1) Has an advanced illness, attested by the patient's treating physician;(2) Has considered all other treatment options currently approved by the United States Food and Drug Administration;(3) Has received a recommendation from the patient's treating physician for an investigational drug, biological product, or device;(4) Has given written, informed consent for the use of the investigational drug, biological product, or device; and(5) Has documentation from the patient's treating physician that the patient meets requirements pursuant to this chapter.Added by S.L. 2015, ch. 188,s. 2, eff. 7/1/2015.